Valuation: Anupam Rasayan India Ltd

Market Cap 141B 1.46B 1.28B 1.19B 1.1B 2.06B 2.1B 14.24B 5.56B 69.09B 5.48B 5.37B 239B P/E 2026
81.6x
P/E 2027 * 41.9x
Enterprise Value 146B 1.51B 1.33B 1.24B 1.14B 2.13B 2.17B 14.76B 5.76B 71.61B 5.68B 5.56B 248B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.28x
Free-Float
16.12%
Yield 2026
0.12%
Yield 2027 * 0.16%
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-06 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
06-04 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
05-25 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
05-23 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-23 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
05-23 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
05-23 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-23 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-23 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
02-28 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
02-16 Anupam Rasayan India's Consolidated Profit Rises in Fiscal Q3 MT
1 day-0.97%
1 week-2.26%
Current month-2.00%
1 month-3.37%
3 months-7.76%
6 months-0.03%
Current year-6.05%
1 week 1,227.7
Extreme 1227.7
1,274
1 month 1,227.7
Extreme 1227.7
1,294.5
Current year 1,162.3
Extreme 1162.3
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Operating Officer 54 23/02/2021
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%-2.26%+7.26%+26.48% 1.48B
-1.40%-2.63%-2.74%+39.10% 75.11B
-6.09%-6.28%-12.41%+11.51% 38.38B
-2.28%-4.85%-23.04%-40.36% 31.09B
-0.19%+1.02%+22.96%+33.65% 26.65B
+0.38%+2.89%+22.20%+10.18% 22.47B
+0.16%-3.08%+68.46%-6.93% 19.77B
-1.60%+1.88%-40.93%-39.04% 18.85B
-0.46%-6.28%+40.45%-45.87% 13.85B
-2.68%-2.48%-2.42%-11.70% 13.75B
Average -1.51%-0.94%+7.98%-2.30% 26.14B
Weighted average by Cap. -1.83%-0.84%+3.18%+6.20%

Financials

2026 2027 *
Net sales 22.24B 230M 202M 188M 173M 325M 331M 2.24B 876M 10.89B 864M 846M 37.75B 37.23B 386M 339M 315M 290M 543M 554M 3.76B 1.47B 18.23B 1.45B 1.42B 63.19B
Net income 1.59B 16.46M 14.46M 13.43M 12.36M 23.19M 23.63M 160M 62.59M 778M 61.77M 60.44M 2.7B 3.37B 34.89M 30.66M 28.46M 26.2M 49.16M 50.09M 340M 133M 1.65B 131M 128M 5.72B
Net Debt 5.16B 53.43M 46.95M 43.59M 40.13M 75.28M 76.7M 521M 203M 2.53B 201M 196M 8.76B 18.21B 189M 166M 154M 142M 266M 271M 1.84B 717M 8.92B 708M 692M 30.9B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
23/07/26 ₹1,239.10 -0.97% 96,728
22/07/26 ₹1,251.20 -1.20% 139,009
21/07/26 ₹1,266.40 -0.12% 335,951
20/07/26 ₹1,267.90 +0.03% 473,915
17/07/26 ₹1,267.50 -0.12% 123,952
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,239.10INR
Average target price
1,143.00INR
Spread / Average Target
-7.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock